Lithospring is a strategic intelligence research firm specialized in Contingent Event Impact Deduction (CEID) and the discovery and monitoring of alternative signals.

Moderna

Collaboration

In March 2024, Blackstone Life Sciences announced a new collaboration to advance Moderna’s influenza mRNA vaccine program, for which BXLS will provide up to $750M of funding. This landmark transaction showcases our long-standing strategy to collaborate with the world’s leading life science companies to advance their critical path products.

Collaboration Image
OUR BELIEFS

Everything we do is guided by the following core belief:

There are no isolated events.

Directly acquired data is just the tip of the iceberg; the real intelligence lies in what can be inferred beneath the surface.

Intelligence, not judgment

We deliver objective and accurate information, rather than providing specific action recommendations.

Timely, Accurate, and Intuitive

We want our users to feel empowered and at ease when accessing information, rather than overwhelmed and lost.

Legal and compliant.

We operate in strict adherence to industry standards and legal frameworks.

Business purposes only

Our mandate is strictly commercial. We do not engage in political affairs, military intelligence, or the surveillance of private individuals.

OUR CLIENTS

Obtaining more information is always better for any enterprise.

Detailed text about services for Institutional Investors.

Detailed text about services for Financial Advisors & Individual Investors.

Detailed text about services for Family Offices, Endowments & Foundations.

Detailed text about services for Insurers.

Contact Us Now